Lou, Z., Wang, X., Hu, C., Liu, W., & Ji, Y. (2024). Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer. Pakistan Journal of Medical Sciences, 40(7). https://doi.org/10.12669/pjms.40.7.9681